75A50323F80022↗
Heyltex Corporation received this contract from Aspr/Orm-Sns, Office of Assistant Secretary for Preparedness and Response: $4.14M obligated so far for drugs and biologicals. Its period of performance ended 2024-10-31.
Key facts · data as of Oct 26, 2026
- Recipient
- Heyltex Corporation
- Awarding agency
- Office of Assistant Secretary for Preparedness and Response (Department of Health and Human Services)
- Contracting office
- Aspr/Orm-Sns (75A503)
- Obligated to date
- $4.14M
- Potential value
- $4.14M
- Ends
- 2024-10-31
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.
Cite this page: SpendQuery, Award 75A50323F80022, data as of Oct 26, 2026, https://spendquery.com/award?id=CONT_AWD_75A50323F80022_7505_V797D70258_3600
Heyltex Corporation: all federal awards · Department of Health and Human Services: spending · Aspr/Orm-Sns: what it buys
FUNDING RECEIVED TO PURCHASE PRUSSIAN BLUE (RADIOGARDASE), INSOLUBLE CAP, 500MG ORAL NEEDED IN ORDER TO SUPPORT EMERGENCY RESPONSES
What it is
- Product or service
- Drugs and Biologicals (PSC 6505)
- Industry
- Pharmaceutical Preparation Manufacturing (NAICS 325412)
- Contracting office
- Aspr/Orm-Sns (75A503)
- Competition
- Full and open competition · 1 offer received
- Pricing
- Firm fixed price
- How it was bought
- GSA Schedule · under V797D70258
- Where the work is
- Dekalb, GA · district GA-04
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
4 actions since 2023-07-25. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2024-09-28 | P00003 | Change order | $0 | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE A NO COST EXTENSION TO EXTEND THE PERIOD OF PERFORMANCE. |
| 2024-02-22 | P00002 | Administrative change | $0 | FUNDING RECEIVED TO PURCHASE PRUSSIAN BLUE (RADIOGARDASE), INSOLUBLE CAP, 500MG ORAL NEEDED IN ORDER TO SUPPORT EMERGENCY RESPONSES |
| 2023-10-03 | P00001 | Administrative change | $0 | FUNDING RECEIVED TO PURCHASE PRUSSIAN BLUE (RADIOGARDASE), INSOLUBLE CAP, 500MG ORAL NEEDED IN ORDER TO SUPPORT EMERGENCY RESPONSES |
| 2023-07-25 | 0 | $4.14M | FUNDING RECEIVED TO PURCHASE PRUSSIAN BLUE (RADIOGARDASE), INSOLUBLE CAP, 500MG ORAL NEEDED IN ORDER TO SUPPORT EMERGENCY RESPONSES |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗